tirzepatide surpass cvot Inside SURPASS-CVOT With Dr. Stephen Nicholls: vs Dulaglutide on Cardiovascular Outcomes Tirzepatide for diabetes: on track

Youre in control The pill, the patch, the ring, and more

Patient education emphasizes the importance of regular eye examinations, glycemic and blood pressure control, and self-care for eye health Conduct frequent visual examinations using appropriate tools and techniques to monitor changes in visual acuity and identify potential signs of retinopathy progression

Certainty of evidence At the class-level, certainty of evidence was highest for the GLP-1RA class compared with placebo, with high certainty observed for CV mortality, all-cause mortality, and non-fatal stroke, and moderate certainty for MACE and non-fatal MI, secondary to heterogeneity or imprecision for certain outcomes (Supplementary Table S25)

Estos efectos tpicamente disminuyen con el tiempo a medida que el cuerpo se adapta al medicamento